期刊文献+

天津市医务人员和监狱服刑人员对丙型肝炎的认知情况及干预效果 被引量:11

Viral hepatitis C knowledge awareness and intervention effect among doctors and prisoners in Tianjin City
原文传递
导出
摘要 目的了解天津市医务人员和监狱服刑人员对丙型肝炎(以下简称丙肝)的认知现状及对其健康干预的工作效果。方法调查人群选自天津市医疗机构的医务人员和在天津监狱的服刑人员;采用编制的丙肝知识调查表,干预前调查对丙肝知识的知晓情况及危险行为,经过健康干预后,用相同问卷再次调查知晓情况。结果医务人员干预前丙肝知识知晓率为74.96%,干预后达97.83%(P<0.01);服刑人员干预前丙肝知晓率为28.65%,干预后增至99.91%(P<0.01)。监狱服刑人员既往共用过注射器的占33.20%,共用牙刷或剃刀的占34.40%,输血和美容美体合计占32.80%。结论医务人员对丙肝防治知识掌握不够全面准确;服刑人员既往感染危险行为比例高,知识认知情况较差;通过人群宣传干预,可明显提高知晓率。 [ Objective ] To investigate the viral hepatitis C knowledge awareness and intervention effect among doctors and prisoners in Tianjin City. [ Methods] Prisoners and doctors were respectively recruited from prisons and hospitals, and 2 times investigation was carried out with the hepatitis C knowledge questionnaire for each person before and after education interventions in order to mas- ter their hepatitis C knowledge awareness and risk behavior. [ Results] The awareness rate of doctors and prisoners was 74.96% and 28.65% , and after intervention, the corresponding rate was increased to 97.83% and 99.91% (P 〈 0.01 }. The prisoners risk behaviors history of sharing syringes, tooth brushes/razors, blood transfused/body beauty proportion was respectively up to 33.20% , 34.40% and 32.80%. [ Conclusion] The doctors do not cover the hepatitis C knowledge completely and accurately. The prisoners have high proportion of past risk behaviors and poor awareness. Health interventions can significantly improve the aware- ness of hepatitis C knowledge.
出处 《职业与健康》 CAS 2013年第12期1500-1501,共2页 Occupation and Health
关键词 病毒性肝炎 丙型肝炎 知晓 干预 Viral hepatitis Hepatitis C Awareness Intervention
  • 相关文献

参考文献6

二级参考文献16

  • 1赵丽华,张树仁,王文蓉.361名特殊女性人群HBV和HCV及HIV病毒感染状况分析[J].实用医技杂志,2006,13(10):1762-1763. 被引量:2
  • 2中华医学会肝病学分会,传染病与寄生虫病学分会.《丙型肝炎防治指南》[Z].2004.
  • 3Xia X, Luo J, Bai J, et al . Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis [J]. Public Health, 2008,122 (10) :990--1003.
  • 4PERZ J F, FARRINGTON L A, PECORARO C, et al. Estimated global prevalence of hepatitis C virus[ C ]//42nd Annual Meeting of the Infection Disease Society of America. Boston, MA, USA: Infections Diseases Society of America, 2004: 33-35.
  • 5DIETERICH D T, RIZZETTO M, MANNS M P. Management of chronic hepatitis C patients who have relapsed or not responded to pegylat2ed interferon alpha plus ribavirin [ J ]. J Viral Hepat, 2009, 16 (12): 833-843.
  • 6中华人民共和国卫生部.GB17010-1997甲型病毒性肝炎诊断标准及处理原则[S].北京:中国标准出版社,2010.
  • 7LANKIN J, JIN L, FARMEN M, et al. Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system [ J ]. J Interferon Cytokine Res, 2003, 23( 5 ): 247-257.
  • 8康来仪,孙永德,郝连杰,曹学义,潘启超.我国丙型和戊型肝炎人群流行病学调查及流行因素的研究[J].中华传染病杂志,1997,15(2):71-75. 被引量:99
  • 9石爽,庄辉.重视丙型肝炎的筛查[J].肝脏,2007,12(5):333-335. 被引量:37
  • 10董瑞玲,汪宁,乔晓春,丁国伟,贾望谦,施小明,Qian Hanzhu,乌正赉,郑锡文.有偿献血者HIV-1、HCV、HBV合并感染调查[J].中国公共卫生,2007,23(12):1420-1422. 被引量:7

共引文献64

同被引文献110

引证文献11

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部